Literature DB >> 10680670

Nuclear cyclin D1 overexpression is a critical event associated with cell proliferation and invasive growth in gallbladder carcinogenesis.

T Itoi1, Y Shinohara, K Takeda, K Nakamura, K Takei, J Sanada, T Horibe, T Saito, K Kasuya, Y Ebihara.   

Abstract

Cyclin D1 overexpression is remarkably frequent in several human carcinomas and is believed to be a critical event in oncogenesis. We examined cyclin D1 expression, p53 expression, and the Ki-67 labeling index by immunostaining in human gallbladder mucosa in conditions varying from normal to malignant tissue. We also examined K-ras codon 12 mutations in these tissues with a two-step polymerase chain reaction. Nuclear cyclin D1 overexpression was observed in 48% of carcinomas occurring independently of adenoma, but not in adenomas, carcinomas arising in adenomas, or nonneoplastic lesions. Cytoplasmic cyclin D1 overexpression was observed in about 15% of abnormal specimens, irrespective of the type of epithelial abnormality. Carcinomas showing nuclear cyclin D1 overexpression had significantly higher Ki-67 labeling indexes than those with no overexpression. Moderately to poorly differentiated adenocarcinomas showed a higher incidence of nuclear cyclin D1 overexpression than papillary to well differentiated carcinomas. Specimens with cyclin D1 overexpression showed a high incidence of lymph permeation, venous permeation, and lymph node metastasis. We conclude that nuclear cyclin D1 overexpression is a critical event importantly associated with cell proliferation and invasive growth in gallbladder carcinogenesis, and that cyclin D1 immunostaining may become a useful marker for evaluating gallbladder carcinomas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10680670     DOI: 10.1007/s005350050027

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  3 in total

1.  The value of thioredoxin family proteins and proliferation markers in dysplastic and malignant gallbladders in patients with primary sclerosing cholangitis.

Authors:  Karouk Said; Hans Glaumann; Mikael Björnstedt; Annika Bergquist
Journal:  Dig Dis Sci       Date:  2012-02-28       Impact factor: 3.199

2.  Targeted deletion of Kcne2 causes gastritis cystica profunda and gastric neoplasia.

Authors:  Torsten K Roepke; Kerry Purtell; Elizabeth C King; Krista M D La Perle; Daniel J Lerner; Geoffrey W Abbott
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

3.  Diosgenin relieves goiter via the inhibition of thyrocyte proliferation in a mouse model of Graves' disease.

Authors:  Hu Cai; Zhe Wang; Hai-qing Zhang; Fu-rong Wang; Chun-xiao Yu; Feng-xia Zhang; Ling Gao; Jian Zhang; Jia-jun Zhao
Journal:  Acta Pharmacol Sin       Date:  2013-11-18       Impact factor: 6.150

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.